These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 32677946)

  • 21. Incidence of airflow limitation in subjects 65-100 years of age.
    Luoto JA; Elmståhl S; Wollmer P; Pihlsgård M
    Eur Respir J; 2016 Feb; 47(2):461-72. PubMed ID: 26677939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vital capacity and COPD: the Swedish CArdioPulmonary bioImage Study (SCAPIS).
    Torén K; Olin AC; Lindberg A; Vikgren J; Schiöler L; Brandberg J; Johnsson Å; Engström G; Persson HL; Sköld M; Hedner J; Lindberg E; Malinovschi A; Piitulainen E; Wollmer P; Rosengren A; Janson C; Blomberg A; Bergström G
    Int J Chron Obstruct Pulmon Dis; 2016; 11():927-33. PubMed ID: 27194908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical impact of the lower limit of normal of FEV
    Liu S; Zhou Y; Liu S; Zou W; Li X; Li C; Deng Z; Zheng J; Li B; Ran P
    Respir Med; 2018 Jun; 139():27-33. PubMed ID: 29857998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lung function decline in relation to diagnostic criteria for airflow obstruction in respiratory symptomatic subjects.
    Akkermans RP; Berrevoets MA; Smeele IJ; Lucas AE; Thoonen BP; Grootens-Stekelenburg JG; Heijdra YF; van Weel C; Schermer TR
    BMC Pulm Med; 2012 Mar; 12():12. PubMed ID: 22439763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estimating population prevalence of potential airflow obstruction using different spirometric criteria: a pooled cross-sectional analysis of persons aged 40-95 years in England and Wales.
    Scholes S; Moody A; Mindell JS
    BMJ Open; 2014 Jul; 4(7):e005685. PubMed ID: 25056983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Airflow limitation by the Global Lungs Initiative equations in a cohort of very old adults.
    Turkeshi E; Vaes B; Andreeva E; Matheï C; Adriaensen W; Van Pottelbergh G; Degryse JM
    Eur Respir J; 2015 Jul; 46(1):123-32. PubMed ID: 25882799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Prevalence of Chronic Obstructive Pulmonary Disease (COPD) and the Heterogeneity of Risk Factors in the Canadian Population: Results from the Canadian Obstructive Lung Disease (COLD) Study.
    Leung C; Bourbeau J; Sin DD; Aaron SD; FitzGerald JM; Maltais F; Marciniuk DD; O'Donnell D; Hernandez P; Chapman KR; Walker B; Road JD; Zheng L; Zou C; Hogg JC; Tan WC;
    Int J Chron Obstruct Pulmon Dis; 2021; 16():305-320. PubMed ID: 33603357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical relevance of fixed ratio vs lower limit of normal of FEV1/FVC in COPD: patient-reported outcomes from the CanCOLD cohort.
    van Dijk W; Tan W; Li P; Guo B; Li S; Benedetti A; Bourbeau J;
    Ann Fam Med; 2015; 13(1):41-8. PubMed ID: 25583891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research - a consensus document from six scientific societies.
    Rossi A; Butorac-Petanjek B; Chilosi M; Cosío BG; Flezar M; Koulouris N; Marin J; Miculinic N; Polese G; Samaržija M; Skrgat S; Vassilakopoulos T; Vukić-Dugac A; Zakynthinos S; Miravitlles M
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2593-2610. PubMed ID: 28919728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interpreting lung function data using 80% predicted and fixed thresholds identifies patients at increased risk of mortality.
    Mannino DM; Diaz-Guzman E
    Chest; 2012 Jan; 141(1):73-80. PubMed ID: 21659434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does Low FEV1 in Addition to Fixed Ratio and/or Lower Limit of Normal of FEV1/FVC Improve Prediction of Mortality in COPD? The NHANES-III-linked-mortality Cohort.
    Odeyemi YE; Lewis O; Ngwa J; Dodd K; Gillum RF; Mehari A
    J Natl Med Assoc; 2019 Feb; 111(1):94-100. PubMed ID: 30064691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estimating the U.S. prevalence of chronic obstructive pulmonary disease using pre- and post-bronchodilator spirometry: the National Health and Nutrition Examination Survey (NHANES) 2007-2010.
    Tilert T; Dillon C; Paulose-Ram R; Hnizdo E; Doney B
    Respir Res; 2013 Oct; 14(1):103. PubMed ID: 24107140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spirometry for the diagnosis of airway obstruction in patients with risk factors for COPD: the GOLD and lower limit of normal criteria.
    Grafino M; Todo-Bom F; Lutas AC; Cabral J; Pereira M; Valença J; Furtado ST
    J Bras Pneumol; 2022; 47(6):e20210124. PubMed ID: 35019054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Misidentification of airflow obstruction: prevalence and clinical significance in an epidemiological study.
    Pothirat C; Chaiwong W; Phetsuk N; Liwsrisakun C
    Int J Chron Obstruct Pulmon Dis; 2015; 10():535-40. PubMed ID: 25792821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What defines abnormal lung function in older adults with chronic obstructive pulmonary disease?
    Bhatt NY; Wood KL
    Drugs Aging; 2008; 25(9):717-28. PubMed ID: 18729545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Twelve-year cumulative incidence of airflow obstruction among Japanese males.
    Omori H; Nagano M; Funakoshi Y; Onoue A; Mihara S; Marubayashi T; Kohrogi H; Aizawa H; Katoh T
    Intern Med; 2011; 50(15):1537-44. PubMed ID: 21804278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study.
    Vollmer WM; Gíslason T; Burney P; Enright PL; Gulsvik A; Kocabas A; Buist AS
    Eur Respir J; 2009 Sep; 34(3):588-97. PubMed ID: 19460786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Occupational exposure to vapor, gas, dust, or fumes and chronic airflow limitation, COPD, and emphysema: the Swedish CArdioPulmonary BioImage Study (SCAPIS pilot).
    Torén K; Vikgren J; Olin AC; Rosengren A; Bergström G; Brandberg J
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3407-3413. PubMed ID: 29238185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Parameter D: New Measure of Airflow Obstruction.
    Bhatt SP; Nakhmani A; Thimmegowda NM; Sthanam V; Wilson CG; Bhakta NR; Kim YI; Bodduluri S
    Ann Am Thorac Soc; 2023 Jul; 20(7):993-1002. PubMed ID: 36989246
    [No Abstract]   [Full Text] [Related]  

  • 40. Prevalence of obstructive lung disease in an African country using definitions from different international guidelines: a community based cross-sectional survey.
    Pefura-Yone EW; Kengne AP; Balkissou AD; Magne-Fotso CG; Ngo-Yonga M; Boulleys-Nana JR; Efe-de-Melingui NR; Ndjeutcheu-Moualeu PI; Mbele-Onana CL; Kenmegne-Noumsi EC; Kolontchang-Yomi BL; Theubo-Kamgang BJ; Ebouki ER; Djuikam-Kamga CK; Amougou F; Mboumtou L; Petchou-Talla EL; Kuaban C;
    BMC Res Notes; 2016 Feb; 9():124. PubMed ID: 26917543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.